Search Results - "Boersma, L. J."

Elicitation of preferences in the second half of the shared decision making process needs attention; a qualitative study by Savelberg, W, Smidt, M, Boersma, L J, van der Weijden, T

“…It is known that the use of a Patient Decision Aid (PtDA), combined with advice for professionals on how and when to use it, can enhance the involvement of…”
Get full text

Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08) by van Roozendaal, L M, Vane, M L G, van Dalen, T, van der Hage, J A, Strobbe, L J A, Boersma, L J, Linn, S C, Lobbes, M B I, Poortmans, P M P, Tjan-Heijnen, V C G, Van de Vijver, K K B T, de Vries, J, Westenberg, A H, Kessels, A G H, de Wilt, J H W, Smidt, M L

“…Studies showed that axillary lymph node dissection can be safely omitted in presence of positive sentinel lymph node(s) in breast cancer patients treated with…”
Get full text

Preoperative breast radiation therapy: Indications and perspectives by Lightowlers, S.V., Boersma, L.J., Fourquet, A., Kirova, Y.M., Offersen, B.V., Poortmans, P., Scholten, A.N., Somaiah, N., Coles, C.E.

“…Preoperative breast radiation therapy (RT) is not a new concept, but older studies failed to change practice. More recently, there has been interest in…”
Get full text

Economic evaluation of four follow-up strategies after curative treatment for breast cancer: Results of an RCT by Kimman, M.L, Dirksen, C.D, Voogd, A.C, Falger, P, Gijsen, B.C.M, Thuring, M, Lenssen, A, van der Ent, F, Verkeyn, J, Haekens, C, Hupperets, P, Nuytinck, J.K.S, van Riet, Y, Brenninkmeijer, S.J, Scheijmans, L.J.E.E, Kessels, A, Lambin, Ph, Boersma, L.J

“…Abstract Background An economic evaluation was performed alongside a randomised controlled trial (ISRCTN 74071417) investigating the cost-effectiveness of…”
Get full text

Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms by Boersma, L J, van den Brink, M, Bruce, A M, Shouman, T, Gras, L, te Velde, A, Lebesque, J V

“…To investigate whether Dose-Volume Histogram (DVH) parameters can be used to identify risk groups for developing late gastrointestinal (GI) and genitourinary…”
Get more information

Three large trials on radiotherapy for early breast cancer: What did we learn? by Boersma, L.J., Murrer, L.H.P.

Get full text

Follow-up after curative treatment for breast cancer: Why do we still adhere to frequent outpatient clinic visits? by Kimman, M.L, Voogd, A.C, Dirksen, C.D, Falger, P, Hupperets, P, Keymeulen, K, Hebly, M, Dehing, C, Lambin, Ph, Boersma, L.J

“…Abstract Follow-up after curative treatment for breast cancer consists of frequent outpatient clinic visits, scheduled at regular intervals. Its aim is…”
Get full text

The Assisi think tank focus review on postoperative radiation for lobular breast cancer by Kaidar-Person, O., Ratosa, I, Franco, P., Masiello, V., Marazzi, F., Pedretti, S., Ciabattoni, A., Leonardi, M.C., Tramm, T., Coles, CE, Meattini, I, Arenas, M., Offersen, B.V., Boersma, L.J., Valentini, V., Dodwell, D., Poortmans, P., Aristei, C., Borghesi, Simona, Krug, David, Montero Luis, Angel, Nardone, Valerio, Bölükbaşi, Yasemin, Kouloulias, Vassilis, Palumbo, Isabella, Perrucci, Elisabetta, Rivera, Sofia, Lozza, Laura, Krengli, Marco, Trigo, Lurdes

“…•Invasive lobular carcinoma (ILC) is the second most common breast cancer type.•There are limited data to guide locoregional therapy for ILC.•Recommendations…”
Get full text

Does lack of deeper understanding of shared decision making explains the suboptimal performance on crucial parts of it? An example from breast cancer care by Savelberg, W., Boersma, L.J., Smidt, M., Goossens, M.F.J., Hermanns, R., van der Weijden, T.

“…Although most of the clinicians in breast cancer care seem to approve of shared decision making (SDM), actual implementation is limited. The aim of this study…”
Get full text

Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trial by Wintraecken, V.M., Boersma, L.J., van Roozendaal, L.M., de Vries, J., van Kuijk, S.M.J., Vane, M.L.G., van Dalen, T., van der Hage, J.A., Strobbe, L.J.A., Linn, S.C., Lobbes, M.B.I., Poortmans, P.M.P, Tjan-Heijnen, V.C.G., van de Vijver, K.K.B.T., Westenberg, A.H., de Wilt, J.H.W., Smidt, M.L., Simons, J.M.

“…•In the BOOG 2013-08 trial, RT-protocol adherence was 98.5%.•Patients in a subanalysis received a mean breast dose of ≥95% of the prescribed dose.•The majority…”
Get full text

Model-Based Selection for Proton Therapy in Breast Cancer: Development of the National Indication Protocol for Proton Therapy and First Clinical Experiences by Boersma, L.J., Sattler, M.G.A., Maduro, J.H., Bijker, N., Essers, M., van Gestel, C.M.J., Klaver, Y.L.B., Petoukhova, A.L., Rodrigues, M.F., Russell, N.S., van der Schaaf, A., Verhoeven, K., van Vulpen, M., Schuit, E., Langendijk, J.A.

“…Proton therapy is a radiation technique that yields less dose in normal tissues than photon therapy. In the Netherlands, proton therapy is reimbursed if the…”
Get full text

Contemporary risks of local and regional recurrence and contralateral breast cancer in patients treated for primary breast cancer by Aalders, K.C, van Bommel, A.C.M, van Dalen, T, Sonke, G.S, van Diest, P.J, Boersma, L.J, van der Heiden- van der Loo, M

“…Abstract Introduction Breast cancer treatment has evolved extensively over the past two decades with a shift towards less invasive local treatment and…”
Get full text

Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer by Seppenwoolde, Y, Muller, S H, Theuws, J C, Baas, P, Belderbos, J S, Boersma, L J, Lebesque, J V

“…To determine local dose-effect relations for lung perfusion and density changes due to irradiation for patients with non-small-cell lung cancer (NSCLC) and to…”
Get more information

What do patients and health care professionals view as important attributes in radiotherapy decisions? Input for a breast cancer patient decision aid by Raphael, D.B., ter Stege, J.A., Russell, N.S., Boersma, L.J., van der Weijden, T.

“…There is increased attention for shared decision making (SDM) when deciding on radiotherapy for selected patients with Stage 0–2 breast cancer. This study…”
Get full text

Implementing a patient decision aid, a process evaluation of a large-scale pre- and post-implementation trial by Raphael Daniela, D. B., Russell, N. S., van Werkhoven, E., Immink, J. M., Westhoff, D. P. G., Stenfert Kroese, M. C., Stam, M. R., van Maurik, L. M., van Gestel, C. M. J., van der Weijden, T., Boersma, L. J.

“…Purpose Patient decision aids (PtDAs) have been reported to have a positive influence on patients making a health care decision in trials. Nevertheless,…”
Get full text

Postmastectomy Radiation Therapy Planning After Immediate Implant-based Reconstruction Using the European Society for Radiotherapy and Oncology-Advisory Committee in Radiation Oncology Practice Consensus Guidelines for Target Volume Delineation by Kaidar-Person, O., Nissen, H.D., Yates, E.S., Andersen, K., Boersma, L.J., Boye, K., Canter, R., Costa, E., Daniel, S., Hol, S., Jensen, I., Lorenzen, E.L., Mjaaland, I., Nielsen, M.E.K., Poortmans, P., Vikström, J., Webb, J., Offersen, B.V.

“…To evaluate how common radiation therapy techniques perform in the setting of the new European Society for Radiotherapy and Oncology-Advisory Committee in…”
Get full text

The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07) by van Roozendaal, L M, de Wilt, J H W, van Dalen, T, van der Hage, J A, Strobbe, L J A, Boersma, L J, Linn, S C, Lobbes, M B I, Poortmans, P M P, Tjan-Heijnen, V C G, Van de Vijver, K K B T, de Vries, J, Westenberg, A H, Kessels, A G H, Smidt, M L

“…Trials failed to demonstrate additional value of completion axillary lymph node dissection in case of limited sentinel lymph node metastases in breast cancer…”
Get full text

Risk communication in a patient decision aid for radiotherapy in breast cancer: How to deal with uncertainty? by Raphael, D.B., Russell, N.S., Immink, J.M., Westhoff, P.G., Stenfert Kroese, M.C., Stam, M.R., van Maurik, L.M., van den Bongard, H.J.G.D., Maduro, J.H., Sattler, M.G.A., van der Weijden, T., Boersma, L.J.

“…Patient decision aids for oncological treatment options, provide information on the effect on recurrence rates and/or survival benefit, and on side-effects…”
Get full text

Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: Results of a 2 x 2 randomised controlled trial by KIMMAN, M. L, DIRKSEN, C. D, HUPPERETS, P, NUYTINCK, J. K. S, VAN RIET, Y, BRENNINKMEIJER, S. J, SCHEIJMANS, L. J. E. E, KESSELS, A, LAMBIN, Ph, BOERSMA, L. J, VOOGD, A. C, FALGER, P, GIJSEN, B. C. M, THURING, M, LENSSEN, A, VAN DER ENT, F, VERKEYN, J, HAEKENS, C

Get full text

Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: An individual patient data meta‐analysis of 22 RCTs by Kalter, J., Verdonck‐de Leeuw, I.M., Sweegers, M.G., Aaronson, N.K., Jacobsen, P.B., Newton, R.U., Courneya, K.S., Aitken, J.F., Armes, J., Arving, C., Boersma, L.J., Braamse, A.M.J., Brandberg, Y., Chambers, S.K., Dekker, J., Ell, K., Ferguson, R.J., Gielissen, M.F.M., Glimelius, B., Goedendorp, M.M., Graves, K.D., Heiney, S.P., Horne, R., Hunter, M.S., Johansson, B., Kimman, M.L., Knoop, H., Meneses, K., Northouse, L.L., Oldenburg, H.S., Prins, J.B., Savard, J., Beurden, M., Berg, S.W., Brug, J., Buffart, L.M.

“…Objective This individual patient data (IPD) meta‐analysis aimed to evaluate the effects of psychosocial interventions (PSI) on quality of life (QoL),…”
Get full text